These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
426 related articles for article (PubMed ID: 19506335)
1. Predictors of appropriate implantable cardioverter-defibrillator therapy during long-term follow-up of patients with coronary artery disease. Blumer J; Wolber T; Hellermann J; Holzmeister J; Binggeli C; Duru F; Brunckhorst C Int Heart J; 2009 May; 50(3):313-21. PubMed ID: 19506335 [TBL] [Abstract][Full Text] [Related]
2. Factors predisposing to ventricular tachyarrhythmia leading to appropriate ICD intervention in patients with coronary artery disease or non-ischaemic dilated cardiomyopathy. Lelakowski J; Piekarz J; Rydlewska A; Majewski J; Senderek T; Ząbek A; Małecka B Kardiol Pol; 2012; 70(12):1264-75. PubMed ID: 23264245 [TBL] [Abstract][Full Text] [Related]
3. Determinants of patient survival rate after implantation of a cardioverter-defibrillator without resynchronisation capability. Lelakowski J; Piekarz J; Rydlewska A; Majewski J; Senderek T; Ząbek A; Małecka B Kardiol Pol; 2012; 70(11):1099-110. PubMed ID: 23180517 [TBL] [Abstract][Full Text] [Related]
4. Left ventricular ejection fraction normalization in cardiac resynchronization therapy and risk of ventricular arrhythmias and clinical outcomes: results from the Multicenter Automatic Defibrillator Implantation Trial With Cardiac Resynchronization Therapy (MADIT-CRT) trial. Ruwald MH; Solomon SD; Foster E; Kutyifa V; Ruwald AC; Sherazi S; McNitt S; Jons C; Moss AJ; Zareba W Circulation; 2014 Dec; 130(25):2278-86. PubMed ID: 25301831 [TBL] [Abstract][Full Text] [Related]
5. Clinical Predictors of Recurrent Ventricular Arrhythmias in Secondary Prevention Implantable Cardioverter Defibrillator Recipients With Coronary Artery Disease - Lower Left Ventricular Ejection Fraction and Incomplete Revascularization. Takano T; Tanaka K; Ozaki K; Sato A; Iijima K; Yanagawa T; Izumi D; Ozawa T; Fuse K; Sato M; Tanabe N; Minamino T Circ J; 2018 Nov; 82(12):3037-3043. PubMed ID: 30305485 [TBL] [Abstract][Full Text] [Related]
6. The implantable cardioverter defibrillator and primary prevention of sudden death: the Multicenter Automatic Defibrillator Implantation Trial and the Coronary Artery Bypass Graft (CABG)-Patch Trial. Block M; Breithardt G Am J Cardiol; 1999 Mar; 83(5B):74D-78D. PubMed ID: 10089844 [TBL] [Abstract][Full Text] [Related]
7. Implantable cardioverter-defibrillators and prevention of sudden cardiac death in hypertrophic cardiomyopathy. Maron BJ; Spirito P; Shen WK; Haas TS; Formisano F; Link MS; Epstein AE; Almquist AK; Daubert JP; Lawrenz T; Boriani G; Estes NA; Favale S; Piccininno M; Winters SL; Santini M; Betocchi S; Arribas F; Sherrid MV; Buja G; Semsarian C; Bruzzi P JAMA; 2007 Jul; 298(4):405-12. PubMed ID: 17652294 [TBL] [Abstract][Full Text] [Related]
8. Left ventricular ejection fraction and absence of ACE inhibitor/angiotensin II receptor blocker predicts appropriate defibrillator therapy in the primary prevention population. Obeyesekere MN; Chan W; Stub D; Prabhu S; Teo EP; Toogood G; Mariani J; Broughton A; Kistler PM Pacing Clin Electrophysiol; 2010 Jun; 33(6):696-704. PubMed ID: 20059719 [TBL] [Abstract][Full Text] [Related]
9. Long-term arrhythmia-free survival in patients with severe left ventricular dysfunction and no inducible ventricular tachycardia after myocardial infarction. Zaman S; Narayan A; Thiagalingam A; Sivagangabalan G; Thomas S; Ross DL; Kovoor P Circulation; 2014 Feb; 129(8):848-54. PubMed ID: 24381209 [TBL] [Abstract][Full Text] [Related]
10. Incidence of and predictors for appropriate implantable cardioverter-defibrillator therapy in patients with a secondary preventive implantable cardioverter-defibrillator indication. Schaer B; Kühne M; Reichlin T; Osswald S; Sticherling C Europace; 2016 Feb; 18(2):227-31. PubMed ID: 26063686 [TBL] [Abstract][Full Text] [Related]
11. Reversible Cause of Cardiac Arrest and Secondary Prevention Implantable Cardioverter Defibrillators in Patients With Coronary Artery Disease: Value of Complete Revascularization and LGE-CMR. van der Lingen ACJ; Becker MAJ; Kemme MJB; Rijnierse MT; Spoormans EM; Timmer SAJ; van Rossum AC; van Halm VP; Germans T; Allaart CP J Am Heart Assoc; 2021 Apr; 10(8):e019101. PubMed ID: 33821672 [TBL] [Abstract][Full Text] [Related]
12. Impact of left ventricular ejection fraction on occurrence of ventricular events in defibrillator patients with coronary artery disease. Schaer B; Sticherling C; Szili-Torok T; Osswald S; Jordaens L; Theuns DA Europace; 2011 Nov; 13(11):1562-7. PubMed ID: 21712284 [TBL] [Abstract][Full Text] [Related]
13. Normalization of Left Ventricular Ejection Fraction and Incidence of Appropriate Antitachycardia Therapy in Patients With Implantable Cardioverter Defibrillator for Primary Prevention of Sudden Death. House CM; Nguyen D; Thomas AJ; Nelson WB; Zhu DW J Card Fail; 2016 Feb; 22(2):125-32. PubMed ID: 26522819 [TBL] [Abstract][Full Text] [Related]
15. New primary prevention trials of sudden cardiac death in patients with left ventricular dysfunction: SCD-HEFT and MADIT-II. Klein H; Auricchio A; Reek S; Geller C Am J Cardiol; 1999 Mar; 83(5B):91D-97D. PubMed ID: 10089848 [TBL] [Abstract][Full Text] [Related]
16. Impact of Chronic Total Coronary Occlusion on Recurrence of Ventricular Arrhythmias in Ischemic Secondary Prevention Implantable Cardioverter-Defibrillator Recipients (VACTO Secondary Study): Insights From Coronary Angiogram and Electrogram Analysis. Nombela-Franco L; Iannaccone M; Anguera I; Amat-Santos IJ; Sanchez-Garcia M; Bautista D; Calvelo MN; Di Marco A; Moretti C; Pozzi R; Scaglione M; Cañadas V; Sandin-Fuentes M; Arenal A; Bagur R; Perez-Castellano N; Fernandez-Perez C; Gaita F; Macaya C; Escaned J; Fernández-Lozano I JACC Cardiovasc Interv; 2017 May; 10(9):879-888. PubMed ID: 28473110 [TBL] [Abstract][Full Text] [Related]